Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Coherus Biosciences Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
CHRS
Nasdaq
2833
https://www.coherus.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Coherus Biosciences Inc
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 24th, 2024 2:02 pm
Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years
- Apr 11th, 2024 11:05 am
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
- Apr 8th, 2024 12:30 pm
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript
- Mar 16th, 2024 7:35 pm
Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations
- Mar 15th, 2024 10:17 am
Why Coherus Biosciences Stock Tumbled on Thursday
- Mar 14th, 2024 10:28 pm
Q4 2023 Coherus BioSciences Inc Earnings Call
- Mar 14th, 2024 11:15 am
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...
- Mar 13th, 2024 9:32 pm
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
- Mar 13th, 2024 8:01 pm
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop, institutional owners may be forced to take severe actions
- Mar 6th, 2024 10:39 am
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
- Mar 5th, 2024 9:01 pm
Coherus Completes Divestiture of Ophthalmology Franchise
- Mar 4th, 2024 6:00 am
Coherus BioSciences Announces New Employment Inducement Grants
- Feb 23rd, 2024 10:33 pm
Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
- Feb 21st, 2024 1:30 pm
Why Coherus BioSciences Stock Jumped Today
- Feb 6th, 2024 10:16 pm
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
- Feb 5th, 2024 1:00 pm
Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be
- Jan 25th, 2024 10:27 am
Why Coherus BioSciences Stock Is Sinking Today
- Jan 23rd, 2024 4:37 pm
Why Coherus Biosciences Popped Today
- Jan 22nd, 2024 8:41 pm
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal
- Jan 22nd, 2024 6:15 am
Scroll